Skip to main content
. 2023 Mar 30;13:5192. doi: 10.1038/s41598-023-30909-0

Table 3.

Treatment related TEAEs.

System organ class
Preferred term
Treatment
SB-121 (N = 15)
n (%)
Placebo (N = 15)
n (%)
Number of Subjects with at least one study treatment related TEAE 3 (20.0) 4 (26.7)
Blood and lymphatic system disorders 1 (6.7) 0
 Leukocytosis 1 (6.7) 0
Gastrointestinal disorders 3 (20.0) 4 (26.7)
 Diarrhea 2 (13.3) 3 (20.0)
 Abdominal pain 0 1 (6.7)
 Abdominal pain upper 1 (6.7) 0
 Vomiting 0 1 (6.7)